Table 4 Adverse events
From: Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children
Adverse events | N (%) | 95% CI |
|---|---|---|
PONV | 20 (0.58) | 0.30–0.80 |
Significant SpO2 reduction | 6 (0.17) | 0–0.30 |
Upper airway obstruction | 3 (0.09) | 0–0.20 |
Rash | 2 (0.06) | 0–0.10 |
Bradycardia requiring drug intervention | 1 (0.03) | 0–0.10 |
Delayed awakening | 1 (0.03) | 0–0.10 |